Highest-materiality recent filing
Genesco CSO Parag Desai to retire Oct 31, 2026; transition to part-time Aug 7
Parag Desai transitions to part-time SVP, Chief Strategy and Digital Officer on Aug 7, 2026; retires Oct 31, 2026.
Genesco shareholders re-elect all nine board nominees; reject dissident slate from Bradley Radoff
All nine company-nominated directors elected with ~8.4M votes each; dissident nominees Ballard and Poskon received ~1M votes.
Genesco names Jonathan Collins as CFO, effective August 3, 2026
Jonathan Collins appointed SVP, Finance and CFO; starts Aug 3, 2026.
Genesco reports Q1 sales beat, raises FY2027 EPS outlook; launches $40-50M cost program
Net sales of $487M rose 3% YoY; comparable sales increased 2% with 3% same-store growth.
Genesco appoints Ashley Randolph as Chief Accounting Officer effective May 5, 2026
Ashley Randolph, 20-year company veteran and former VP/Corporate Controller, named VP and CAO.
Genesco adopts new Short-Term Incentive Plan for FY2027, replacing EVA Plan
STIP effective FY2027; replaces Fourth Amended and Restated EVA Plan.
Genesco CEO Mimi Vaughn adds principal accounting officer role after CFO departure
Cassandra E. Harris ceased as principal accounting officer effective March 25, 2026, after FY2026 10-K filing.
Journeys Group Q4 comp sales +12%; overall comps +9% (stores +9%, e-commerce +8%).
Genesco CFO Cassandra Harris resigns effective March 6; CEO Mimi Vaughn named interim CFO
Harris resigns to pursue non-retail opportunities; departure not related to any disagreement with the company.
Genesco extends credit facility maturity to Jan 2031, adjusts pricing grid
Fourth Amendment extends maturity of revolving credit facility to January 16, 2031.
Genesco Q4-to-date comparable sales +9% YoY; raises FY2026 adjusted EPS guidance to at least $1.30
Total comparable sales up 9% for the 8 weeks ended Dec 27, 2025; same-store sales +10%, e-commerce +9%.
Genesco Q3 sales +3% to $616M; adj EPS $0.79; cuts FY adj EPS guidance to ~$0.95
Q3 net sales $616M (+3% YoY); GAAP EPS $0.51 vs ($1.76); Non-GAAP EPS $0.79 vs $0.61.
Genesco Q2 net sales +4% to $546M, beats expectations; raises FY sales outlook
Q2 GAAP EPS ($1.79) vs ($0.91) last year; Non-GAAP EPS ($1.14) vs ($0.83); operating loss $14.4M.
Genesco shareholders elect all nine director nominees at 2025 annual meeting
All nine director nominees elected with votes ranging from ~6.5M to ~6.8M for each.
Genesco Q1 sales +4% YoY, comparable sales +5%; loss narrows; reiterates FY adj EPS $1.30-$1.70
Net sales $474M (+4% YoY); comparable sales +5% with Journeys +8%, Schuh +1%, J&MG -2%.
Genesco formally engages Deloitte & Touche as FY2026 independent auditor
Deloitte completed client acceptance procedures and was formally engaged on May 15, 2025.
Genesco dismisses EY as auditor, appoints Deloitte effective April 30, 2025
Audit Committee dismissed Ernst & Young LLP and appointed Deloitte & Touche LLP as independent auditor, effective April 30, 2025.
Genesco Q4 comparable sales +10%; adjusted EPS $3.26 beats prior year $2.59
Q4 net sales $746M (+1%); comparable sales +10% led by Journeys +14% and e-commerce +18%.
The amendments apply to certain executive officers, excluding CEO Mimi E. Vaughn and Parag D. Desai.
Genesco Q4-to-date comparable sales up 10% YoY; reaffirms FY25 EPS guidance
Quarter-to-date comparable sales (8 wks ended Dec 28, 2024) increased 10% vs prior year.
Genesco CFO Thomas George retires; Sandra Harris assumes principal accounting officer role
Thomas A. George retired as Senior VP, Finance and CFO effective December 12, 2024, as part of planned retirement.
Genesco beats Q3 expectations; raises FY2025 adjusted EPS guidance to $0.80-$1.00
Net sales $596M (+3% YoY); comparable sales +6% driven by Journeys +11% comp.
Genesco appoints Sandra Harris as CFO, replacing retiring Thomas George
Sandra Harris named CFO effective Oct 7, 2024, succeeds Thomas George who retires Dec 12.
Genesco Q2 net sales $525M, non-GAAP EPS ($0.83) vs ($0.85) YoY; reaffirms FY EPS $0.60-$1.00
GAAP operating loss $10.3M (2.0% of sales) vs $38.6M loss last year; adjusted operating loss $9.3M.
Genesco CFO Thomas George adds principal accounting officer role; CAO Baxter to resign July 31
Thomas A. George, CFO and SVP-Finance, appointed additional role of principal accounting officer.
Genesco shareholders elect all nine directors and approve all proposals at annual meeting
All nine director nominees elected, with 'for' votes ranging from ~8.35M to ~8.72M.
Genesco Q1 operating loss $32.1M; reaffirms FY2025 EPS guidance $0.60-$1.00
Net sales $458M (-5% YoY); comparable sales -5%; e-commerce +3% to 23% of retail sales.
Genesco increases share repurchase authorization by $50M to $250M
Existing $200M authorization: $189.5M used on 3.9M shares since Sep 2019, leaving $10.5M.
Genesco adopts Executive Severance Plan covering key officers with 12-24 month severance
Plan covers key management, including named executive officers, upon involuntary termination or good reason resignation.
Genesco Q4 non-GAAP EPS $2.59; FY24 GAAP loss; FY25 adj EPS guidance $0.60-$1.00
Q4 net sales $739M (+2% vs 13-wk prior year); comps down 4%; e-commerce 27% of retail.
Genesco cuts FY2024 adjusted EPS guidance to $0.65-$0.85 from $1.50-$2.00
Q4-to-date comparable sales decreased 4% YoY; store sales -6%, direct sales +3%.
Genesco Q3 sales down 4% to $579M, adj EPS $0.57; lowers FY outlook to $1.50-$2.00
Net sales $579M, down 4% YoY; comparable sales -4% (stores -7%, direct +8%).
Genesco names Andy Gray President of Journeys Group, effective Jan 3, 2024
Andy Gray, former Foot Locker global president, appointed President of Journeys Group, effective Jan 3, 2024.
Mario Gallione to retire effective February 3, 2024, after 44 years at Genesco.
Genesco posts Q2 GAAP loss per share of $2.79; non-GAAP loss $0.85; sales down 2%
Net sales $523M, down 2% YoY; GAAP loss from cont. ops $31.6M ($2.79 loss per share).
Board authorized $50M increase to its $200M buyback program; total remaining authorization now $60.5M.
Genesco Q1 loss per share $1.60; guides FY24 adjusted EPS $2.00-$2.50
Net sales $483M (-7% YoY); GAAP loss from continuing ops $18.9M ($1.60 loss per share).
Genesco amends EVA incentive plan, caps bonuses at 3x target, phases out bonus banks
Compensation committee amended EVA plan to cap bonuses at 3x target and eliminate future bonus bank contributions starting FY2024.
Genesco Q4 EPS $3.06 vs $3.48 YoY; FY23 non-GAAP EPS $5.59; guides FY24 $5.10-$5.90
Q4 net sales $725M flat YoY; GAAP EPS $3.23 vs $4.41; non-GAAP EPS $3.06 vs $3.48.
Genesco Q4-to-date comp sales up 3%; guides FY adjusted EPS to low end of $5.50-$5.90
Q4-to-date comparable sales (stores + direct) +3% YoY; same-store sales -2%, direct +22%.
Genesco Q3 adj. EPS falls to $1.65 from $2.36; lowers FY23 guidance to $5.50-$5.90
Revenue $604M, +1% YoY; comps +3%; e-commerce 18% of retail sales.
Genesco appoints Best Buy CFO and Sephora EVP to board; two directors retire
Matt Bilunas (Best Buy CFO) and Carolyn Bojanowski (Sephora EVP) join board effective Jan 29, 2023.
Genesco board approves amended bylaws to align with SEC Rule 14a-19 on director nominations
Amended bylaws require shareholders nominating directors to fully comply with Rule 14a-19, including proxy solicitation.
Genesco Q2 adj EPS $0.59 vs $1.05 last year; cuts FY23 EPS guidance to $6.25-$7.00
Net sales $535M, down 4% YoY but up 10% vs pre-pandemic Q2FY20; retail comps -2%.
All nine director nominees elected; votes ranged from 10.7M to 11.7M for, with broker non-votes of ~447k.
Genesco Q1 adj EPS $0.44 beats expectations; reaffirms FY23 adj EPS $7.00-$7.75
Net sales $521M, down 3% YoY but up 5% vs pre-pandemic Q1FY20 with 90 fewer stores.
Q4 net sales $728M (+14% YoY, +7% vs pre-pandemic); gross margin 48.9% (+310bps vs last year).
Genesco adds $100M to share repurchase program; total authorization now $101M
Board approved $100M increase to existing repurchase program; prior remaining authorization was $1M.
Genesco amends credit agreement: maturity extended to 2027, margin reduced 1%
Extended maturity to Jan 28, 2027; removed $17.5M term loan.
Total overall sales for the 8 weeks ended Dec 25, 2021 increased 18% vs FY21 and 9% vs FY20.
On June 29, 2026, Genesco Inc. (the “Company”) announced the appointment of Jonathan Collins as Senior Vice President, Finance and Chief Financial Officer.
As such, as of the Effective Date, Ms. Vaughn will no longer serve as the Company’s Interim Chief Financial Officer and principal financial officer.
As such, as of the Effective Date, Ms. Vaughn will no longer serve as the Company’s principal accounting officer.
On May 5, 2026, Genesco Inc. (the “Company”) announced the appointment of Ashley Randolph as Chief Accounting Officer and principal accounting officer.
On October 1, 2024, the Company also announced that Thomas A. George, Senior Vice President, Finance and Chief Financial Officer, will be leaving the Company as part of his planned retirement.
On October 1, 2024, Genesco Inc. (the “Company”) announced the appointment of Cassandra “Sandra” Harris as Senior Vice President, Finance and Chief Financial Officer of the Company, effective October 7, 2024
On June 27, 2024, Thomas A. George, Genesco Inc.’s (the “Company”) chief financial officer and senior vice president – finance, was appointed to serve in the additional role of the Company’s principal accounting officer
on June 27, 2024, Brently G. Baxter notified the Company that he will resign as the Company’s vice president and chief accounting officer effective July 31, 2024.
On November 28, 2023, Genesco Inc. (the “Company”) announced that Andrew I. Gray has been named President, Journeys Group and Senior Vice President of the Company, effective January 3, 2024 (the “Effective Date”).
On August 30, 2023, Genesco Inc. (the “Company”) announced the upcoming retirement of Mario Gallione, President of Journeys and Senior Vice President, with an expected effective date of February 3, 2024.
Matthew C. Diamond and Kevin McDermott notified the Board on November 21, 2022 of their decisions to retire and not stand for re-election at the 2023 Annual Meeting.
approved an increase in the size of the Board from nine to eleven directors effective January 29, 2023, the first day of the Company’s 2024 fiscal year, and appointed Matt Bilunas and Carolyn Bojanowski to fill the resulting vacancies
Max materiality 0.90 · Median 0.65 · Most common event earnings